Profile picture

Doctor Tomoaki Okada

Kagawa Prefectural Central Hospital, Takamatsu (Japan)
Follow
Logo ESC

Contributor content

Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects
Presentation
Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects
Feasibility and safety of early initiation of a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor in patients with acute myocardial infarction undergoing primary PCI
Presentation
Feasibility and safety of early initiation of a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor in patients with acute myocardial infarction undergoing primary PCI

ESC 365 is supported by